Ribo Submits European Clinical Trial Application for a Novel Dual Targeting siRNA SR122 for Mixed and Severe Dyslipidemia, Further Strengthening Its Footprint in the Area of Lipid DisorderContributed by: PR NewswireImagesTagsSuzhou-Ribo-Life-Scie